<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37507580</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7209</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>563</EndPage><MedlinePgn>547-563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10456-023-09885-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-COVID-19 syndrome (PCS) is a lingering disease with ongoing symptoms such as fatigue and cognitive impairment resulting in a high impact on the daily life of patients. Understanding the pathophysiology of PCS is a public health priority, as it still poses a diagnostic and treatment challenge for physicians.</AbstractText><AbstractText Label="METHODS">In this prospective observational cohort study, we analyzed the retinal microcirculation using Retinal Vessel Analysis (RVA) in a cohort of patients with PCS and compared it to an age- and gender-matched healthy cohort (n&#x2009;=&#x2009;41, matched out of n&#x2009;=&#x2009;204).</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">PCS patients exhibit persistent endothelial dysfunction (ED), as indicated by significantly lower venular flicker-induced dilation (vFID; 3.42%&#x2009;&#xb1;&#x2009;1.77% vs. 4.64%&#x2009;&#xb1;&#x2009;2.59%; p&#x2009;=&#x2009;0.02), narrower central retinal artery equivalent (CRAE; 178.1 [167.5-190.2] vs. 189.1 [179.4-197.2], p&#x2009;=&#x2009;0.01) and lower arteriolar-venular ratio (AVR; (0.84 [0.8-0.9] vs. 0.88 [0.8-0.9], p&#x2009;=&#x2009;0.007). When combining AVR and vFID, predicted scores reached good ability to discriminate groups (area under the curve: 0.75). Higher PCS severity scores correlated with lower AVR (R&#x2009;=&#x2009;-&#xa0;0.37 p&#x2009;=&#x2009;0.017). The association of microvascular changes with PCS severity were amplified in PCS patients exhibiting higher levels of inflammatory parameters.</AbstractText><AbstractText Label="CONCLUSION">Our results demonstrate that prolonged endothelial dysfunction is a hallmark of PCS, and impairments of the microcirculation seem to explain ongoing symptoms in patients. As potential therapies for PCS emerge, RVA parameters may become relevant as clinical biomarkers for diagnosis and therapy management.</AbstractText><AbstractText Label="TRIAL REGISTRATION">This study was previously registered at ClinicalTrials ("All Eyes on PCS-Analysis of the Retinal Microvasculature in Patients with Post-COVID-19 Syndrome". NCT05635552. https://clinicaltrials.gov/ct2/show/NCT05635552 ). Persistent endothelial dysfunction in post-COVID-19 syndrome. Acute SARS-CoV-2 infection indirectly or directly causes endotheliitis in patients. N&#x2009;=&#x2009;41 PCS patients were recruited and retinal vessel analysis was performed to assess microvascular endothelial function. Images of SVA and DVA are illustrative for RVA data analysis. For each PCS patient and healthy cohort, venular vessel diameter of the three measurement cycles was calculated and plotted on a diameter-time curve. Patients exhibited reduced flicker-induced dilation in veins (vFID) measured by dynamic vessel analysis (DVA) and lower central retinal arteriolar equivalent (CRAE) and arteriolar-venular ratio (AVR) and a tendency towards higher central retinal venular equivalent (CRVE) when compared to SARS-CoV-2 infection na&#xef;ve participants. Created with BioRender.com.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuchler</LastName><ForeName>Timon</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nthner</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medizinische Klinik Und Poliklinik IV, LMU University Hospital Munich, Ziemssenstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hausinger</LastName><ForeName>Renate</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streese</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Health Care, Niederrhein University of Applied Sciences, Krefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xf6;hnl</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesseler</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negele</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assali</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbajo-Lozoya</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lech</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medizinische Klinik Und Poliklinik IV, LMU University Hospital Munich, Ziemssenstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Heike</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Nu&#xdf;baumstra&#xdf;e 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubbe</LastName><ForeName>Hans Christian</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Medizinische Klinik Und Poliklinik II, LMU University Hospital Munich, Marchioninistra&#xdf;e 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanssen</LastName><ForeName>Henner</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Sport, Exercise and Health, Preventive Sports Medicine and Systems Physiology, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotilar</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aachen University of Applied Sciences, Heinrich-Mussmann-Str. 1, 52428, J&#xfc;lich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Medicine, Institute for AI and Informatics in Medicine, Technical University of Munich, Klinikum Rechts Der Isar, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heemann</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmaderer</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. christoph.schmaderer@mri.tum.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany. christoph.schmaderer@mri.tum.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05635552</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Angiogenesis. 2023 Nov;26(4):565. doi: 10.1007/s10456-023-09892-7</RefSource><PMID Version="1">37612533</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012171" MajorTopicYN="N">Retinal Vessels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="Y">Vascular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Retinal microvasculature</Keyword></KeywordList><CoiStatement>All authors declare that they have no financial or non-financial interests directly or indirectly related to the work submitted for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37507580</ArticleId><ArticleId IdType="pmc">PMC10542303</ArticleId><ArticleId IdType="doi">10.1007/s10456-023-09885-6</ArticleId><ArticleId IdType="pii">10.1007/s10456-023-09885-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zayet S, et al. Post-COVID-19 Syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in nord franche-comt&#xe9; hospital, france. Microorganisms. 2021;9(8):1719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28(10):2117&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence: Clinical Guidelines, in COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020, National Institute for Health and Care Excellence (NICE) Copyright &#xa9; NICE 2020: London</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D, et al. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022;10:975992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, et al. Association of Post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw Open. 2023;6(2):e2256152&#x2013;e2256152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, et al. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, et al. Long covid: where we stand and challenges ahead. Cell Death Differ. 2022;29(10):1891&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, X., et al., Damage to endothelial barriers and its contribution to long COVID. Angiogenesis, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Reports Medicine. 2022;3(6):100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S-W, Ilyas I, Weng J-P. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2022 doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, et al. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26(1):53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, et al. Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Med (Lausanne) 2021;8:676554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299003</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansiroglu AK, et al. Evaluation of Endothelial Dysfunction in COVID-19 With Flow-Mediated Dilatation. Arq Bras Cardiol. 2022;119(2):319&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363072</ArticleId><ArticleId IdType="pubmed">35674570</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, et al. Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study. Vascul Pharmacol. 2022;144:106975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front Cardiovasc Med. 2021;8:745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. 2022;28(1):122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanssen H, Streese L, Vilser W. Retinal vessel diameters and function in cardiovascular risk and disease. Prog Retin Eye Res. 2022;91:101095.</Citation><ArticleIdList><ArticleId IdType="pubmed">35760749</ArticleId></ArticleIdList></Reference><Reference><Citation>Streese L, et al. Normative data and standard operating procedures for static and dynamic retinal vessel analysis as biomarker for cardiovascular risk. Sci Rep. 2021;11(1):14136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266855</ArticleId><ArticleId IdType="pubmed">34238996</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander Y, et al. Endothelial function in cardiovascular medicine: a consensus paper of the european society of cardiology working groups on atherosclerosis and vascular biology, aorta and peripheral vascular diseases, coronary pathophysiology and microcirculation, and thrombosis. Cardiovasc Res. 2020;117(1):29&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797212</ArticleId><ArticleId IdType="pubmed">32282914</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidelmann SB, et al. Retinal Vessel Calibers in Predicting Long-Term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Circulation. 2016;134(18):1328&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219936</ArticleId><ArticleId IdType="pubmed">27682886</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;gele MP, et al. Retinal microvascular dysfunction in heart failure. Eur Heart J. 2018;39(1):47&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">29069316</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, et al. The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2019;21(10):1207&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">31373139</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. Type 2 diabetes and HbA(1c) are independently associated with wider retinal arterioles: the Maastricht study. Diabetologia. 2020;63(7):1408&#x2013;1417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286946</ArticleId><ArticleId IdType="pubmed">32385602</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nthner R, et al. Impaired Retinal Vessel Dilation Predicts Mortality in End-Stage Renal Disease. Circ Res. 2019;124(12):1796&#x2013;1807.</Citation><ArticleIdList><ArticleId IdType="pubmed">30929571</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nthner R, et al. Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients. Cardiovasc Res. 2022;118(16):3239&#x2013;3249.</Citation><ArticleIdList><ArticleId IdType="pubmed">35576475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard LD, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology. 1999;106(12):2269&#x2013;2280.</Citation><ArticleIdList><ArticleId IdType="pubmed">10599656</ArticleId></ArticleIdList></Reference><Reference><Citation>Streese L, et al. High-intensity interval training modulates retinal microvascular phenotype and DNA methylation of p66Shc gene: a randomized controlled trial (EXAMIN AGE) Eur Heart J. 2019;41(15):1514&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pubmed">31323685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TY, et al. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology. 2004;111(6):1183&#x2013;1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15177969</ArticleId></ArticleIdList></Reference><Reference><Citation>Streese L, et al. Physical activity may drive healthy microvascular ageing via downregulation of p66Shc. Eur J Prev Cardiol. 2020;27(2):168&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">31610708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, et al. The fatigue severity scale: application to patients With multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome. J. Chronic Fatigue Syndr. 2003;11(1):7&#x2013;115.</Citation></Reference><Reference><Citation>Lorenz G, et al. Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation. Kidney Int. 2018;93(1):221&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">28941940</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31&#x2013;s34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398292</ArticleId><ArticleId IdType="pubmed">30930717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel E, Vilser W, Lanzl I. Age, blood pressure, and vessel diameter as factors influencing the arterial retinal flicker response. Invest Ophthalmol Vis Sci. 2004;45(5):1486&#x2013;1492.</Citation><ArticleIdList><ArticleId IdType="pubmed">15111606</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagi M, et al. Is the association between smoking and the retinal venular diameter reversible following smoking cessation? Invest Ophthalmol Vis Sci. 2014;55(1):405&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">24302587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotliar KE, et al. Dynamic retinal vessel response to flicker in obesity: a methodological approach. Microvasc Res. 2011;81(1):123&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">21094174</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):192&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20(1):138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng C, Motto DG, Di Paola J. Diagnostic approach to von Willebrand disease. Blood. 2015;125(13):2029&#x2013;2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375103</ArticleId><ArticleId IdType="pubmed">25712990</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A, et al. Retinal vessels modifications in acute and post-COVID-19. Sci Rep. 2021;11(1):19373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481283</ArticleId><ArticleId IdType="pubmed">34588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JJ, et al. Retinal vessel diameters and obesity: a population-based study in older persons. Obesity (Silver Spring) 2006;14(2):206&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">16571845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology &amp; microcirculation, ESC Working Group on thrombosis and the association for acute cardiovascular Care (ACVC), in collaboration with the european heart rhythm association (EHRA) Cardiovasc Res. 2021;117(14):2705&#x2013;2729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik MK, et al. Endothelial dysfunction in ME/CFS patients. PLoS ONE. 2023;18(2):e0280942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894436</ArticleId><ArticleId IdType="pubmed">36730360</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K, et al. Reduced endothelial function in myalgic encephalomyelitis/chronic fatigue syndrome-results from open-label cyclophosphamide intervention study. Front Med. 2021;8:294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019750</ArticleId><ArticleId IdType="pubmed">33829023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kell DB, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a role for viruses. Blood Rev. 2023 doi: 10.1016/j.blre.2023.101075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2023.101075</ArticleId><ArticleId IdType="pmc">PMC10027292</ArticleId><ArticleId IdType="pubmed">36963989</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022;20(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Long COVID: a proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc. 2022;43(3):187&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22(1):211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Investi. 2023 doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol. 2007;19(6):636&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">17917546</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borne P, et al. The multifaceted functions of CXCL10 in cardiovascular disease. Biomed Res Int. 2014;2014:893106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017714</ArticleId><ArticleId IdType="pubmed">24868552</ArticleId></ArticleIdList></Reference><Reference><Citation>Leighton SP, et al. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23(1):48&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754468</ArticleId><ArticleId IdType="pubmed">29133955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyra e Silva NM, et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer&#x2019;s disease. Transl Psychiatry. 2021;11(1):251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080782</ArticleId><ArticleId IdType="pubmed">33911072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131:105295&#x2013;105295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, et al. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021;11(1):12775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211641</ArticleId><ArticleId IdType="pubmed">34140539</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, et al. A persistent neutrophil-associated immune signature characterizes post&#x2013;COVID-19 pulmonary sequelae. Sci Transl Med. 2022;14(671):eabo5795.</Citation><ArticleIdList><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante, C.T., et al., 2022 Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up. medRxiv : the preprint server for health sciences, 2022: p. 2022.12.21.22283753.</Citation></Reference><Reference><Citation>Nafisa A, et al. Endothelial function and dysfunction: Impact of metformin. Pharmacol Ther. 2018;192:150&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">30056057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>